FCF Grants Awarded in 2020
Total grants: 7
- Cancer Research Institute (CRI) fellowship program – renewal — Cancer Research Institute
- A phase I/II study of nivolumab plus 5-fluorouracil plus interferon-α2b for unresectable fibrolamellar hepatocellular carcinoma — Principal investigator(s): Sunyoung Lee, Ahmed Kaseb — MD Anderson Cancer Center
- Creating a fibrolamellar cancer dependency map — Principal investigator(s): Jesse Boehm — Broad Institute of MIT and Harvard
- Identifying therapeutic vulnerabilities in fibrolamellar carcinoma — Principal investigator(s): Praveen Sethupathy — Cornell University
- DNAJB1-PKAc-β-catenin-ALCD-dependent activation of cancer genes plays an essential role in fibrolamellar hepatocellular carcinoma — Principal investigator(s): Nikolai Timchenko — Cincinnati Children’s Hospital Medical Center
- Fibrolamellar carcinoma model development and analysis — Principal investigator(s): Nabeel Bardeesy — Massachusetts General Hospital
- Modulating stromal-immune cell interactions to activate anti-tumor immunity to fibrolamellar carcinoma — Principal investigator(s): Venu Pillarisetty — University of Washington
This list represents the complete set of Fibrolamellar Cancer Foundation grants awarded in 2020. The name of the grant is listed, along with the institution receiving the grant and the principal investigator.